Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 22, 2024
UK Cancer Healthcare Professionals Collaborating With Colleagues in Low- and Middle-Income Countries: Mapping the Extent and Nature of Partnerships; Future Implications
K Diprose, K Wakeham, P Lewis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 30, 2016
Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directions
B S Poudyal, G S Shrestha, S Tuladhar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2018
Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment
I R Weir, G D Marshall, J I Schneider, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 4, 2021
Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation
A Fundytus, J C Wells, S Sharma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 16, 2025
ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update
N I Cherny, D Trapani, M Galotti, et al.
ESMO Open
|
February 3, 2026
Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression
G M Iannantuono, T Giovagnoli, L Mastrantoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2022
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit
S F Oosting, J Barriuso, A Bottomley, et al.
ESMO Open
|
April 22, 2021
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
B Gyawali, E G E de Vries, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2025
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)
N I Cherny, S F Oosting, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2023
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0
B Kiesewetter, U Dafni, E G E de Vries, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 22, 2024
UK Cancer Healthcare Professionals Collaborating With Colleagues in Low- and Middle-Income Countries: Mapping the Extent and Nature of Partnerships; Future Implications
K Diprose, K Wakeham, P Lewis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 30, 2016
Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directions
B S Poudyal, G S Shrestha, S Tuladhar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2018
Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment
I R Weir, G D Marshall, J I Schneider, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 4, 2021
Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation
A Fundytus, J C Wells, S Sharma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 16, 2025
ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update
N I Cherny, D Trapani, M Galotti, et al.
ESMO Open
|
February 3, 2026
Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression
G M Iannantuono, T Giovagnoli, L Mastrantoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2022
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit
S F Oosting, J Barriuso, A Bottomley, et al.
ESMO Open
|
April 22, 2021
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
B Gyawali, E G E de Vries, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2025
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)
N I Cherny, S F Oosting, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2023
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0
B Kiesewetter, U Dafni, E G E de Vries, et al.
Page
of 3